Nurix Therapeutics, Inc. (NRIX) vs Recursion Pharmaceuticals, Inc. (RXRX)
A side-by-side comparison of Nurix Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NRIX
Nurix Therapeutics, Inc.
$22.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RXRX
Recursion Pharmaceuticals, Inc.
$4.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NRIX vs RXRX
growth of $100 · dividends reinvested · last 5yNRIX -26.2% (-5.9%/yr)RXRX -73.4% (-23.3%/yr)NRIX compounded faster over this window
NRIX RXRX
NRIX vs RXRX: by the numbers
- •RXRX is the larger company ($2.43B vs $2.35B market cap).
- •Both run net losses; NRIX's is the smaller (-928.44% vs -945.92% net margin).
- •RXRX grew revenue faster over the past five years (45.50% vs 9.96% CAGR).
Metrics side by side
Valuation
| Metric | NRIX | RXRX |
|---|---|---|
| P/S ratio | 63.79 | 44.29 |
| P/B ratio | 5.83 | 2.65 |
Profitability
| Metric | NRIX | RXRX |
|---|---|---|
| Gross margin | 77.55% | -61.96% |
| Operating margin | -340.16% | -867.87% |
| Net margin | -928.44% | -945.92% |
| ROE | -84.78% | -56.71% |
| ROIC | -77.92% | -49.78% |
Growth (annualized)
| Metric | NRIX | RXRX |
|---|---|---|
| Revenue CAGR (5Y) | 9.96% | 45.50% |
| Total return CAGR (5Y) | -5.51% | -25.86% |
Frequently asked
- Which has grown faster, NRIX or RXRX?
- Over the past five years, RXRX grew revenue faster — NRIX at a 9.96% CAGR versus RXRX at 45.50%.
- How have NRIX and RXRX total returns compared?
- Over the past 5 years, NRIX delivered -5.51% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Nurix Therapeutics ROERecursion Pharmaceuticals ROENurix Therapeutics operating marginRecursion Pharmaceuticals operating marginNurix Therapeutics revenue growthRecursion Pharmaceuticals revenue growthNurix Therapeutics free cash flowRecursion Pharmaceuticals free cash flow
Nurix Therapeutics & Recursion Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.